U.S. flag

An official website of the United States government, Department of Justice.

Prescription Drug Monitoring Program: North Carolina State Profile (2021)

NCJ Number
Date Published
11 pages

The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) reports 2020 data and 2021 features of the North Carolina state Prescription Drug Monitoring Program (PDMP).



The acronym of the North Carolina PDMP is NC CSRS. It is administered by the North Carolina Department of Health and Human Services, Division of Mental Health, Developmental Disabilities, and Substance Abuse Services. The email address is provided, along with the URLs of the main website and related websites for enrollment and query. Contact information is provided for the Drug Control Unit Manager and the Program Consultant. In 2020, the state population was 10,453,948, and there were 55,835 DEA-registered prescribers and 2,259 DEA-registered dispensers. There are 25 types of reports listed as being available from the PDMP. The PDMP is funded from the state general fund and controlled substance registration fees. The budget amount for 2021 is not reported. There are seven members of the PDMP staff, with five performing operational responsibilities, one responsible for technical issues, and one performing analytical/epidemiological work. Key dates are provided for the establishment and development of the PDMP, and access information is reported for statutes and rules relevant to the establishment and operations of the PDMP. Various capabilities and policies of the PDMP are noted. Under a data retention policy, all information is purged every 6 years, with de-identified data retained. Training in the features and use of the PDMP is available for prescribers and dispensers but is not required before PDMP use. Law enforcement agencies’ access to PDMP data requires an active investigation or a court order/approval. Enrollment in and use of PDMP is required for prescribers and dispensers. Veterinarians are required to report their prescriptions. Data monitored or accessible pertain to drugs listed in Schedules II-V. Technological capabilities, interstate data sharing, and types of authorized PDMP reports are indicated.


Date Published: January 1, 2021